Marc Carrier: TRIM-Line Trial Evaluates VTE Prevention in Cancer
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Thrombosis and Haemostasis, adding:
“An important knowledge gap: patients with cancer and a central venous catheter face an increased risk of venous thromboembolism, yet definitive evidence to support routine thromboprophylaxis after catheter insertion is lacking.
TRIM-Line is an ongoing randomized trial comparing rivaroxaban 10 mg daily with placebo for 90 days to determine whether prophylaxis reduces VTE with an acceptable bleeding risk.
We have enrolled 500 Canadian patients!
We are planning to open sites in France, Saudi Arabia and Italy.”
Title: Primary Thromboprophylaxis in Patients with Malignancy and Central Venous Catheters: TRIM-Line Randomized Controlled Trial—Design and Rationale
Authors: Tzu-Fei Wang, Rick Ikesaka, Isabelle Mahé, Danny Hill, Catherine Sperlich, Vicky Tagalakis, Sudeep Shivakumar, Blair Leonard, Andrea Cervi, Philip G. Kuruvilla, Fréderic Larose, Davide Matino, Steffan Frosi Stella, Chantal Séguin, Abdulrahman Al Raizah, Grégoire Le Gal, Deborah M. Siegal, Aurélien Delluc, Ranjeeta Mallick, Alejandro Lazo-Langner, Cynthia Wu, Dennis Christopher, Marcello Di Nisio, Walter Ageno, Bashour Yazji, Marc Carrier

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics
-
Nov 14, 2026, 23:33Alexandros Makis: Exploring Vascular Mechanisms and Therapeutic Targets in β-Thalassemia